MarketCap
Facebook
X
TelegramQuarterly report 2022-Q3
added 11-03-2022
SeaSpine Holdings Corporation DPO Ratio 2011-2026 | SPNE
Annual DPO Ratio SeaSpine Holdings Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 60.1 | 32.1 | 46.9 | 60.1 | 52 | 56.1 | 81.8 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 81.8 | 32.1 | 55.6 |
Quarterly DPO Ratio SeaSpine Holdings Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 30.4 | - | 82.4 | - | 86.6 | 75.2 | 50.8 | - | 32.5 | 39.2 | 41.1 | - | 47.2 | 47.5 | 56 | - | 59 | 57.8 | 62.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 86.6 | 30.4 | 54.8 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B |  USA |
 |
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | USA |
 |
Align Technology
ALGN
|
33.7 | $ 164.69 | -7.13 % | $ 12.3 B | USA |
 |
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M | USA |
 |
Sintx Technologies
SINT
|
223 | $ 2.32 | -4.13 % | $ 6.43 M | USA |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
Sensus Healthcare
SRTS
|
14.7 | $ 3.8 | -5.24 % | $ 62 M | USA |
 |
Stryker Corporation
SYK
|
70.1 | $ 328.87 | -1.15 % | $ 126 B | USA |
 |
Alphatec Holdings
ATEC
|
73.8 | $ 10.95 | -4.99 % | $ 1.64 B | USA |
 |
Tactile Systems Technology
TCMD
|
24.4 | $ 26.55 | -0.86 % | $ 607 M | USA |
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | USA |
 |
TELA Bio
TELA
|
31.8 | $ 0.66 | -11.27 % | $ 31 M | USA |
 |
Abbott Laboratories
ABT
|
79.7 | $ 105.12 | 0.53 % | $ 183 B | USA |
 |
Tandem Diabetes Care
TNDM
|
35.7 | $ 21.37 | -8.36 % | $ 1.45 B | USA |
 |
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
29.6 | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
Boston Scientific Corporation
BSX
|
61.7 | $ 69.36 | -1.15 % | $ 103 B | USA |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
CONMED Corporation
CNMD
|
57.3 | $ 35.31 | -3.63 % | $ 1.1 B | USA |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
32.2 | - | - | $ 1.08 M | USA |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
Viemed Healthcare
VMD
|
20.1 | $ 9.26 | 0.43 % | $ 360 M | USA |
 |
Cytosorbents Corporation
CTSO
|
125 | $ 0.59 | -1.05 % | $ 32.1 M | USA |
 |
Aethlon Medical
AEMD
|
61.8 | $ 2.19 | -3.52 % | $ 3.42 M | USA |
 |
Varex Imaging Corporation
VREX
|
42.5 | $ 10.81 | 0.23 % | $ 448 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
58.1 | $ 78.73 | -4.1 % | $ 46 B | USA |
 |
Vivos Therapeutics
VVOS
|
98.4 | $ 1.13 | -5.04 % | $ 5.67 M | USA |
 |
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | USA |
 |
Beyond Air
XAIR
|
133 | $ 0.69 | -0.72 % | $ 46.7 M | USA |
 |
Xtant Medical Holdings
XTNT
|
55.7 | $ 0.57 | 0.51 % | $ 76.2 M | USA |
 |
Zimmer Biomet Holdings
ZBH
|
50.4 | $ 88.4 | -0.85 % | $ 18 B | USA |
 |
AdaptHealth Corp.
AHCO
|
43.9 | $ 11.24 | -1.49 % | $ 1.52 B | USA |
 |
Penumbra
PEN
|
26.1 | $ 335.31 | -0.33 % | $ 13 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
79.4 | $ 15.72 | -3.85 % | $ 369 M | USA |
 |
Invacare Corporation
IVC
|
75.6 | - | - | $ 24.7 M | USA |
 |
Ra Medical Systems
RMED
|
1.22 K | - | 10.0 % | $ 610 K | USA |
 |
IRIDEX Corporation
IRIX
|
50.7 | - | - | $ 16 M | USA |